Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non-Small Cell Lung Cancer
David Ball, Alan Mitchell, Dori Giroux, Ramon Rami-Porta
JOURNAL OF THORACIC ONCOLOGY | ELSEVIER SCIENCE INC | Published : 2013
BACKGROUND: Analysis of the International Association for the Study of Lung Cancer database revealed that for patients with completely resected, node-negative, non-small-cell lung cancer (NSCLC), increasing tumor size was associated with worsening survival. This analysis was performed to determine the effect of size on prognosis in patients in the same database but who were treated with radiotherapy or chemoradiotherapy. METHODS: Patients were eligible if they had pathologically confirmed NSCLC, no evidence of distant metastases, intended treatment was radical radiotherapy (minimum 50 Gy) or combined chemotherapy and radiotherapy, no surgery, and tumor diameter was available. RESULTS: Eight ..View full abstract
The International Association for the Study of Lung Cancer Staging Project was funded by a restricted educational grant from Eli Lilly and Company. No individual from the company had any role in evaluating the data or in preparing the article. The project was also supported by the American Joint Committee on Cancer grant Improving American Joint Committee on Cancer/UICC tumor, node, metastasis cancer staging.